Antigen-Agnostic, Trained-Immunity-Driven Antiviral and Adaptive-Immunity-Driven Vaccine Hybrids
Developing broad-spectrum, mutation-agnostic, enduring, economic and noninvasive antivirals and vaccines in one package
About VaxDome
VaxDome Inc. is a startup company founded on the University of North Texas Health Fort Worth campus in 2019, with a mission to develop new classes of antivirals and vaccines that are broad-spectrum, mutation-agnostic, enduring, economic, and noninvasive. We strive to make a positive impact on global health through our innovative solutions.